APUS - Apimeds Pharmaceuticals US Inc.
1.88
0 0%
Share volume: 31,594
Last Updated: 04-21-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.16%
PREVIOUS CLOSE
CHG
CHG%
$1.88
0.00
0.00%
View ratios
| Fiscal Date | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|
| Fiscal Quarter | Q1 2025 | Q3 2025 | |
| Report Date | 05-20-2025 | 11-12-2025 | |
| Assets | |||
| Total Assets | 259.904 K | 9.250 M | |
| Current Assets | 259.904 K | 9.086 M | |
| Inventories | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | |
| Current Cash | 250.342 K | 6.987 M | |
| Total Non-current Assets | 0.000 | 0.000 | |
| Property Plant Equipment | 0.000 | 34.188 K | |
| Other Assets | 0.000 | 129.740 K | |
| Intangible Assets | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||
| Total Liabilities and shareholders’ equity | 259.904 K | 9.250 M | |
| Total liabilities | 2.020 M | 1.089 M | |
| Total current liabilities | 1.770 M | 1.089 M | |
| Accounts Payable | 935.203 K | 567.633 K | |
| Other liabilities | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | |
| Long term debt | 250.000 K | 0.000 | |
| Other liabilities | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | |
| Total Shareholder equity | -1.761 M | 8.161 M | |
| Common stock | 3.034 M | 17.398 M | |
| Retained earnings | -4.794 M | -9.238 M |